ABC / Queensland Cancer Fund / Agilent Technologies / Narod S.A. / Roche Diagnostics / Millipore / Qiagen / Stem Cell Technologies / Becton Dickinson / Merck / Scientific Corp. / Jackson Laboratories / Victorian Cancer Biobank / Nature America Inc. / /
Country
United States / Australia / /
Currency
cent / / /
Event
FDA Phase / Product Issues / /
Facility
US National Cancer Institute / Medical Research Institute / University of Nebraska Medical Center / Royal Melbourne Hospital / WEHI Monoclonal Antibody Facility / University of Queensland / Scale bar / University of Melbourne / Hospital Tissue Bank / Eliza Hall Institute of Medical Research / US National Institute of Diabetes / Monash University / Children’s Medical Research Institute / /
IndustryTerm
bank / /
MedicalCondition
BRCA1-associated basal tumors / Basal tumors / Basal-like breast cancers / carcinoma / breast tumor / breast cancer / cancers / mouse mammary tumor virus / leukemia / tumor / Familial Breast Cancer / breast cancers / hereditary / cancer / tumors / Brca1 deficiency / Kidney Diseases / Diabetes / basal tumor / breast tumors / cholera / carcinomas / similar tumor / basal breast tumors / tumours / /
University of Melbourne / Medical Research Institute / 4The Royal Melbourne Hospital / Royal Melbourne Hospital / US Department of Defense / 8The School of Molecular and Microbial Sciences / University of Queensland / Brisbane / Monash University / Melbourne / 1The Walter and Eliza Hall Institute of Medical Research / 6Peter MacCallum Cancer Centre / 5Children’s Medical Research Institute / Eliza Hall Institute of Medical Research / University of Nebraska / /
Aberrant luminal progenitors as the candidate target population for basal tumor development in BRCA1 mutation carriers